Therapeutic neovascularization for ischemic heart disease.

The Canadian journal of cardiology

Volumn 20 Suppl B, Issue , 2004, Pages

  Lekas, Michael ^a   Kutryk, Michael J B ^a   Latter, David A ^a   Stewart, Duncan J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; RECOMBINANT PROTEIN; VASCULOTROPIN A;

ANGIOGENESIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FOLLOW UP; GENE THERAPY; GENETICS; HEART MUSCLE ISCHEMIA; HUMAN; MALE; METHODOLOGY; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; REVIEW; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

CLINICAL TRIALS, PHASE II; DOUBLE-BLIND METHOD; FEMALE; FIBROBLAST GROWTH FACTORS; FOLLOW-UP STUDIES; GENE THERAPY; HUMANS; MALE; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; RANDOMIZED CONTROLLED TRIALS; RECOMBINANT PROTEINS; REFERENCE VALUES; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 35348908346     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)